A Study of ABM-1310 in Patients With BRAF V600-Mutant Advanced Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jin Li, M.D.
Shanghai East Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Beijing Cancer Hospital
Beijing, Beijing Municipality, China
- Beijing Tsinghua Changgeng Hospital
Beijing, Beijing Municipality, China
- Xuzhou Medical University Affiliated Hospital
Xuzhou, Jiangsu, China
- the First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
- Jilin Cancer Hospital
Changchun, Jilin, China
- Affiliated Cancer Hospital of Shandong First Medical University (shandong Cancer Institute, Shandong Cancer Hospital)
Jinan, Shandong, China
- Huashan Hospital Affiliated To Fudan University
Shanghai, Shanghai Municipality, China
- Shanghai Chest Hospital
Shanghai, Shanghai Municipality, China
- Shanghai East Hospital
Shanghai, Shanghai Municipality, China
- Zhongshan Hospital Affiliated To Fudan University
Shanghai, Shanghai Municipality, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Sept 2022
- Primary completion
- 17 Jun 2024
- Completion
- 17 Jun 2024
- Last update posted
- 29 Nov 2024
- Registered enrollment
- 20
- Registry id
- NCT05501912
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.